Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 976

1.

An Experimental Series Investigating the Effects of Hyperinsulinemic Euglycemia on Myocardial Blood Flow Reserve in Healthy Individuals and on Myocardial Perfusion Defect Size following ST-Segment Elevation Myocardial Infarction.

Nam MCY, Meneses AL, Byrne CD, Richman T, Quah JX, Bailey TG, Hickman I, Anstey C, Askew CD, Senior R, Stanton T, Russell AW, Greaves K.

J Am Soc Echocardiogr. 2020 Apr 1. pii: S0894-7317(20)30018-3. doi: 10.1016/j.echo.2020.01.010. [Epub ahead of print]

PMID:
32247531
2.

Development and validation of a novel non-invasive test for diagnosing fibrotic NASH in patients with biopsy-proven NAFLD.

Gao F, Huang JF, Zheng KI, Pan XY, Ma HL, Liu WY, Byrne CD, Targher G, Li YY, Chen YP, Chan WK, Zheng MH.

J Gastroenterol Hepatol. 2020 Apr 4. doi: 10.1111/jgh.15055. [Epub ahead of print]

PMID:
32246876
3.

Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line.

Byrne CE, Astete CE, Vaithiyanathan M, Melvin AT, Moradipour M, Rankin SE, Knutson BL, Sabliov CM, Martin EC.

Nanomedicine (Lond). 2020 Apr 2. doi: 10.2217/nnm-2020-0010. [Epub ahead of print]

PMID:
32238059
4.

Intercalation, decomposition, entrapment - a new route to graphene nanobubbles.

Zahra KM, Byrne C, Alieva A, Casiraghi C, Walton AS.

Phys Chem Chem Phys. 2020 Mar 30. doi: 10.1039/d0cp00592d. [Epub ahead of print]

PMID:
32227000
5.

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study.

Richardson PG, Bringhen S, Voorhees P, Plesner T, Mellqvist UH, Reeves B, Paba-Prada C, Zubair H, Byrne C, Chauhan D, Anderson K, Nordström E, Harmenberg J, Palumbo A, Sonneveld P.

Lancet Haematol. 2020 Mar 23. pii: S2352-3026(20)30044-2. doi: 10.1016/S2352-3026(20)30044-2. [Epub ahead of print]

PMID:
32213344
6.

Return to Recreational Sport Following Lumbar Fusion.

Jain NS, Lin CC, Halim A, Knight B, Byrne CT, Alluri R, Bhatia NN, Lee YP.

Clin Spine Surg. 2020 Mar 11. doi: 10.1097/BSD.0000000000000980. [Epub ahead of print]

PMID:
32168116
7.

Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.

Zheng KI, Liu WY, Pan XY, Ma HL, Zhu PW, Wu XX, Targher G, Byrne C, Wang XD, Chen YP, Lu F, Zheng MH.

BMJ Open Diabetes Res Care. 2020 Mar;8(1). pii: e001174. doi: 10.1136/bmjdrc-2020-001174.

8.

PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings.

Mantovani A, Taliento A, Zusi C, Baselli G, Prati D, Granata S, Zaza G, Colecchia A, Maffeis C, Byrne CD, Valenti L, Targher G.

Liver Int. 2020 Mar 3. doi: 10.1111/liv.14419. [Epub ahead of print]

PMID:
32125756
9.

Non-invasive liver fibrosis scores are strongly associated with liver cancer mortality in general population without liver disease.

Sung KC, Johnston MP, Lee MY, Byrne CD.

Liver Int. 2020 Feb 23. doi: 10.1111/liv.14416. [Epub ahead of print]

PMID:
32090451
10.

Room-Temperature Production of Nanocrystalline Molybdenum Disulfide (MoS2) at the Liquid-Liquid Interface.

Higgins EPC, McAdams SG, Hopkinson DG, Byrne C, Walton AS, Lewis DJ, Dryfe RAW.

Chem Mater. 2019 Aug 13;31(15):5384-5391. doi: 10.1021/acs.chemmater.8b05232. Epub 2019 Jul 18.

11.

NAFLD as a driver of chronic kidney disease.

Byrne CD, Targher G.

J Hepatol. 2020 Apr;72(4):785-801. doi: 10.1016/j.jhep.2020.01.013. Epub 2020 Feb 12. Review.

PMID:
32059982
12.

Phenotype of genetically confirmed Silver-Russell syndrome beyond childhood.

Lokulo-Sodipe O, Ballard L, Child J, Inskip HM, Byrne CD, Ishida M, Moore GE, Wakeling EL, Fenwick A, Mackay DJG, Davies JH, Temple IK.

J Med Genet. 2020 Feb 13. pii: jmedgenet-2019-106561. doi: 10.1136/jmedgenet-2019-106561. [Epub ahead of print]

13.

PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD.

Hu DS, Zhu SH, Liu WY, Pan XY, Zhu PW, Li YY, Zheng KI, Ma HL, You J, Targher G, Byrne CD, Chen YP, Zheng MH.

Diabetes Metab. 2020 Feb 6. pii: S1262-3636(20)30024-0. doi: 10.1016/j.diabet.2020.02.001. [Epub ahead of print]

PMID:
32035968
14.

Corrigendum to "HEART UK consensus statement on Lipoprotein(a): A call to action" [Atherosclerosis 291 (2019) 62-70].

Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee.

Atherosclerosis. 2020 Mar;296:48. doi: 10.1016/j.atherosclerosis.2020.01.019. Epub 2020 Feb 1. No abstract available.

PMID:
32018073
15.

Complications, morbidity and mortality of nonalcoholic fatty liver disease.

Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G.

Metabolism. 2020 Jan 30:154170. doi: 10.1016/j.metabol.2020.154170. [Epub ahead of print]

PMID:
32006558
16.

Causes of mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol related Fatty Liver Disease (AFLD).

Johnston MP, Patel J, Byrne CD.

Curr Pharm Des. 2020 Jan 27. doi: 10.2174/1381612826666200128094231. [Epub ahead of print]

PMID:
32003662
17.

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.

Scorletti E, Afolabi PR, Miles EA, Smith DE, Almehmadi A, Alshathry A, Childs CE, Del Fabbro S, Beavis J, Moyses HE, Clough GF, Sethi JK, Patel J, Wright M, Breen DJ, Peebles C, Darekar A, Aspinall R, Fowell AJ, Dowman JK, Nobili V, Targher G, Delzenne NM, Bindels LB, Calder PC, Byrne CD.

Gastroenterology. 2020 Jan 25. pii: S0016-5085(20)30124-4. doi: 10.1053/j.gastro.2020.01.031. [Epub ahead of print]

PMID:
31987796
18.

Correction to: Interventions to Reduce Adverse Drug Event-Related Outcomes in Older Adults: A Systematic Review and Meta-analysis.

Tecklenborg S, Byrne C, Cahir C, Brown L, Bennett K.

Drugs Aging. 2020 Feb;37(2):147. doi: 10.1007/s40266-020-00749-y.

PMID:
31984472
19.

In vitro effects of Bifidobacterium lactis-based synbiotics on human faecal bacteria.

Henrique-Bana FC, Wang X, Costa GN, Spinosa WA, Miglioranza LHS, Scorletti E, Calder PC, Byrne CD, Gibson GR.

Food Res Int. 2020 Feb;128:108776. doi: 10.1016/j.foodres.2019.108776. Epub 2019 Nov 8.

PMID:
31955747
20.

Blast traumatic brain injury and serum inflammatory cytokines: a repeated measures case-control study among U.S. military service members.

Rusiecki J, Levin LI, Wang L, Byrne C, Krishnamurthy J, Chen L, Galdzicki Z, French LM.

J Neuroinflammation. 2020 Jan 13;17(1):20. doi: 10.1186/s12974-019-1624-z.

21.

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials.

Mantovani A, Byrne CD, Scorletti E, Mantzoros CS, Targher G.

Diabetes Metab. 2020 Jan 7. pii: S1262-3636(20)30002-1. doi: 10.1016/j.diabet.2019.12.007. [Epub ahead of print]

PMID:
31923578
22.

Interventions to Reduce Adverse Drug Event-Related Outcomes in Older Adults: A Systematic Review and Meta-analysis.

Tecklenborg S, Byrne C, Cahir C, Brown L, Bennett K.

Drugs Aging. 2020 Feb;37(2):91-98. doi: 10.1007/s40266-019-00738-w. Review. Erratum in: Drugs Aging. 2020 Jan 27;:.

PMID:
31919801
23.

Serum concentrations of DDE, PCBs, and other persistent organic pollutants and mammographic breast density in Triana, Alabama, a highly exposed population.

Rusiecki JA, Denic-Roberts H, Byrne C, Cash J, Raines CF, Brinton LA, Zahm SH, Mason T, Bonner MR, Blair A, Hoover R.

Environ Res. 2020 Mar;182:109068. doi: 10.1016/j.envres.2019.109068. Epub 2019 Dec 26.

PMID:
31918312
24.

Investigating temporal microbial dynamics in the rumen of beef calves raised on two farms during early life.

O'Hara E, Kenny DA, McGovern E, Byrne CJ, McCabe MS, Guan LL, Waters SM.

FEMS Microbiol Ecol. 2020 Feb 1;96(2). pii: fiz203. doi: 10.1093/femsec/fiz203.

PMID:
31917419
25.

Quantifying the spatial risk of Avian Influenza introduction into British poultry by wild birds.

Hill A, Gillings S, Berriman A, Brouwer A, Breed AC, Snow L, Ashton A, Byrne C, Irvine RM.

Sci Rep. 2019 Dec 27;9(1):19973. doi: 10.1038/s41598-019-56165-9.

26.

Platelet-rich plasma injection for adults with acute Achilles tendon rupture: the PATH-2 RCT.

Alsousou J, Keene DJ, Harrison P, Hulley P, Wagland S, Thompson JY, Parsons SR, Byrne C, Schlüssel MM, O’Connor HM, Dutton SJ, Lamb SE, Willett K.

Southampton (UK): NIHR Journals Library; 2019 Nov.

27.

A study protocol for a randomised crossover study evaluating the effect of diets differing in carbohydrate quality on ileal content and appetite regulation in healthy humans.

Byrne CS, Blunt D, Burn J, Chambers E, Dagbasi A, Franco Becker G, Gibson G, Mendoza L, Murphy K, Poveda C, Ramgulam A, Tashkova M, Walton G, Washirasaksiri C, Frost G.

F1000Res. 2019 Mar 5;8:258. doi: 10.12688/f1000research.17870.2. eCollection 2019.

28.

Patterns of Religiosity, Death Anxiety, and Hope in a Population of Community-Dwelling Palliative Care Patients in New Zealand-What Gives Hope If Religion Can't?

Byrne CM, Morgan DD.

Am J Hosp Palliat Care. 2020 May;37(5):377-384. doi: 10.1177/1049909119891148. Epub 2019 Dec 9.

PMID:
31818121
29.

Ileo-anal pouch excision and permanent ileostomy - Indications and outcomes from a tertiary centre.

Kalaiselvan R, McWhirter D, Martin K, Byrne C, Rooney PS.

Surgeon. 2019 Dec 5. pii: S1479-666X(19)30141-6. doi: 10.1016/j.surge.2019.11.001. [Epub ahead of print]

PMID:
31813778
30.

Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular risk.

Targher G, Byrne CD.

Eur Heart J. 2020 Jan 7;41(2):331. doi: 10.1093/eurheartj/ehz831. No abstract available.

PMID:
31800051
31.

Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes.

Mantovani A, Turino T, Lando MG, Gjini K, Byrne CD, Zusi C, Ravaioli F, Colecchia A, Maffeis C, Salvagno G, Lippi G, Bonora E, Targher G.

Diabetes Metab. 2019 Nov 28. pii: S1262-3636(19)30184-3. doi: 10.1016/j.diabet.2019.11.004. [Epub ahead of print]

PMID:
31786361
32.

Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD.

Sun DQ, Ye FZ, Kani HT, Yang JR, Zheng KI, Zhang HY, Targher G, Byrne CD, Chen YP, Yuan WJ, Yilmaz Y, Zheng MH.

Diabetes Metab. 2019 Nov 28. pii: S1262-3636(19)30183-1. doi: 10.1016/j.diabet.2019.11.003. [Epub ahead of print]

PMID:
31786360
33.

Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.

Bajaj NS, Singh A, Zhou W, Gupta A, Fujikura K, Byrne C, Harms HJ, Osborne MT, Bravo P, Andrikopolou E, Divakaran S, Bibbo CF, Hainer J, Skali H, Taqueti V, Steigner M, Dorbala S, Charytan DM, Prabhu SD, Blankstein R, Deo RC, Solomon SD, Di Carli MF.

Circulation. 2020 Jan 7;141(1):21-33. doi: 10.1161/CIRCULATIONAHA.119.043916. Epub 2019 Nov 29.

PMID:
31779467
34.

Prepubertal nutrition alters Leydig cell functional capacity and timing of puberty.

Anand-Ivell R, Byrne CJ, Arnecke J, Fair S, Lonergan P, Kenny DA, Ivell R.

PLoS One. 2019 Nov 21;14(11):e0225465. doi: 10.1371/journal.pone.0225465. eCollection 2019.

35.

What's new in NAFLD pathogenesis, biomarkers and treatment?

Byrne CD, Targher G.

Nat Rev Gastroenterol Hepatol. 2020 Feb;17(2):70-71. doi: 10.1038/s41575-019-0239-2. No abstract available.

PMID:
31740806
36.

HEART UK consensus statement on Lipoprotein(a): A call to action.

Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee.

Atherosclerosis. 2019 Dec;291:62-70. doi: 10.1016/j.atherosclerosis.2019.10.011. Epub 2019 Oct 14. Review. Erratum in: Atherosclerosis. 2020 Feb 1;296:48.

37.

Usefulness of Abductive Reasoning in Nursing Education: A Pilot Study.

Mirza NA, Akhtar-Danesh N, Noesgaard C, Martin L, Byrne C.

Nurse Educ. 2019 Nov 1. doi: 10.1097/NNE.0000000000000755. [Epub ahead of print]

PMID:
31688425
38.

Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.

Liu WY, Zheng KI, Pan XY, Ma HL, Zhu PW, Wu XX, Rios RS, Targher G, Byrne CD, Wang XD, Chen YP, Zheng MH.

J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14894. [Epub ahead of print]

PMID:
31677195
39.

Maternal Obesity during Pregnancy Alters Daily Activity and Feeding Cycles, and Hypothalamic Clock Gene Expression in Adult Male Mouse Offspring.

Cleal JK, Bruce KD, Shearer JL, Thomas H, Plume J, Gregory L, Shepard JN, Spiers-Fitzgerald KL, Mani R, Lewis RM, Lillycrop KA, Hanson MA, Byrne CD, Cagampang FR.

Int J Mol Sci. 2019 Oct 30;20(21). pii: E5408. doi: 10.3390/ijms20215408.

40.

Can’t Acopia, Won’t Acopia

Nolan R, Byrne C, Duggan J.

Ir Med J. 2019 Sep 12;112(8):996. No abstract available.

PMID:
31651115
41.

Arsenite and cadmium promote the development of mammary tumors.

Divekar SD, Li HH, Parodi DA, Ghafouri TB, Chen R, Cyrus K, Foxworth AE, Fornace AJ, Byrne C, Martin MB.

Carcinogenesis. 2019 Oct 24. pii: bgz176. doi: 10.1093/carcin/bgz176. [Epub ahead of print]

PMID:
31646340
42.

Nonalcoholic Fatty Liver Disease in Nonobese Subjects of African Origin Has Atypical Metabolic Characteristics.

Thompson DS, Tennant IA, Soares DP, Osmond C, Byrne CD, Forrester TE, Boyne MS.

J Endocr Soc. 2019 Aug 21;3(11):2051-2063. doi: 10.1210/js.2019-00138. eCollection 2019 Nov 1.

43.

Solvothermal synthesis of graphene oxide and its composites with poly(ε-caprolactone).

Chin SJ, Doherty M, Vempati S, Dawson P, Byrne C, Meenan BJ, Guerra V, McNally T.

Nanoscale. 2019 Oct 28;11(40):18672-18682. doi: 10.1039/c9nr04202d. Epub 2019 Oct 7.

PMID:
31588470
44.

Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users.

Sung KC, Huh JH, Ryu S, Lee JY, Scorletti E, Byrne CD, Kim JY, Hyun DS, Ko SB.

J Clin Med. 2019 Oct 1;8(10). pii: E1571. doi: 10.3390/jcm8101571.

45.

Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial.

Byrne C, Pareek M, Vaduganathan M, Biering-Sørensen T, Qamar A, Pandey A, Olesen TB, Olsen MH, Bhatt DL.

Eur Heart J Cardiovasc Pharmacother. 2019 Sep 14. pii: pvz050. doi: 10.1093/ehjcvp/pvz050. [Epub ahead of print]

PMID:
31529024
46.

Multi-drug approaches to NASH: what's in the development pipeline?

Johnston MP, Patel J, Byrne CD.

Expert Opin Investig Drugs. 2020 Feb;29(2):143-150. doi: 10.1080/13543784.2020.1668926. Epub 2019 Sep 23. Review.

PMID:
31524533
47.

PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels.

Sun DQ, Zheng KI, Xu G, Ma HL, Zhang HY, Pan XY, Zhu PW, Wang XD, Targher G, Byrne CD, Chen YP, Yuan WJ, Zheng MH.

Liver Int. 2020 Jan;40(1):107-119. doi: 10.1111/liv.14251. Epub 2019 Oct 7.

PMID:
31519069
48.

Making EGMs Accountable: Can an Informative and Dynamic Interface Help Players Self-regulate?

Byrne CA, Russell AMT.

J Gambl Stud. 2019 Sep 12. doi: 10.1007/s10899-019-09889-2. [Epub ahead of print]

PMID:
31515684
49.

Expression of genes in the skeletal muscle of individuals with cachexia/sarcopenia: A systematic review.

Byrne CA, McNeil AT, Koh TJ, Brunskill AF, Fantuzzi G.

PLoS One. 2019 Sep 9;14(9):e0222345. doi: 10.1371/journal.pone.0222345. eCollection 2019.

50.

The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis.

Walsh CA, Cahir C, Tecklenborg S, Byrne C, Culbertson MA, Bennett KE.

Br J Clin Pharmacol. 2019 Nov;85(11):2464-2478. doi: 10.1111/bcp.14075. Epub 2019 Sep 6. Review.

PMID:
31486099

Supplemental Content

Support Center